Found: 13
Select item for more details and to access through your institution.
Anti-PD1 Consolidation in Patients with Hodgkin Lymphoma at High Risk of Relapse after Autologous Stem Cell Transplantation: A Multicenter Real-Life Study.
- Published in:
- Cancers, 2022, v. 14, n. 23, p. 5846, doi. 10.3390/cancers14235846
- By:
- Publication type:
- Article
Tumor flare reactions and response to lenalidomide in patients with refractory classic Hodgkin lymphoma.
- Published in:
- American Journal of Hematology, 2010, v. 85, n. 1, p. 87, doi. 10.1002/ajh.21571
- By:
- Publication type:
- Article
Rituximab therapy for chronic lymphocytic leukemia‐associated autoimmune hemolytic anemia.
- Published in:
- American Journal of Hematology, 2006, v. 81, n. 8, p. 598, doi. 10.1002/ajh.20665
- By:
- Publication type:
- Article
Efficacy and safety of the third-generation chloroethylnitrosourea fotemustine for the treatment of chemorefractory T-cell lymphomas.
- Published in:
- European Journal of Haematology, 2011, v. 87, n. 6, p. 547, doi. 10.1111/j.1600-0609.2011.01683.x
- By:
- Publication type:
- Article
Improved outcome of patients with relapsed/refractory Hodgkin lymphoma with a new fotemustine-based high-dose chemotherapy regimen.
- Published in:
- British Journal of Haematology, 2016, v. 172, n. 1, p. 111, doi. 10.1111/bjh.13803
- By:
- Publication type:
- Article
A phase II study of dose-dense and dose-intense ABVD ( ABVD<sub>DD-DI</sub>) without consolidation radiotherapy in patients with advanced Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2014, v. 166, n. 1, p. 118, doi. 10.1111/bjh.12862
- By:
- Publication type:
- Article
Biweekly rituximab, cyclophosphamide, vincristine, non-pegylated liposome-encapsulated doxorubicin and prednisone (R-COMP-14) in elderly patients with poor-risk diffuse large B-cell lymphoma and moderate to high 'life threat' impact cardiopathy.
- Published in:
- British Journal of Haematology, 2011, v. 154, n. 5, p. 579, doi. 10.1111/j.1365-2141.2011.08786.x
- By:
- Publication type:
- Article
Use of allogeneic platelet gel in the management of chemotherapy extravasation injuries: a case report.
- Published in:
- OncoTargets & Therapy, 2015, v. 8, p. 401, doi. 10.2147/OTT.S68469
- By:
- Publication type:
- Article
Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 3‐year follow‐up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials.
- Published in:
- Hematological Oncology, 2022, v. 40, n. 4, p. 704, doi. 10.1002/hon.3031
- By:
- Publication type:
- Article
Patients with multiple myeloma infected with COVID-19 during autologous stem cell transplantation.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Post-exposure prophylaxis with sotrovimab for Omicron (B.1.1.529) SARS-CoV-2 variant during the aplastic phase of autologous stem cell transplantation.
- Published in:
- Infectious Agents & Cancer, 2022, v. 17, n. 1, p. 1, doi. 10.1186/s13027-022-00454-y
- By:
- Publication type:
- Article
Atypical COVID-19 dynamics in a patient with mantle cell lymphoma exposed to rituximab.
- Published in:
- Infectious Agents & Cancer, 2021, v. 16, n. 1, p. 1, doi. 10.1186/s13027-021-00376-1
- By:
- Publication type:
- Article
Long-term results of gemcitabine plus oxaliplatin with and without rituximab as salvage treatment for transplant-ineligible patients with refractory/relapsing B-cell lymphoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 5, p. 907, doi. 10.1007/s00280-009-0941-9
- By:
- Publication type:
- Article